RENAISSANCE TECHNOLOGIES LLC

Position in LEXX — Lexaria Bioscience Corp.

CIK 1037389 NEW YORK, NY

Position in LEXX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$12,714

+$3,089 QoQ

Shares Held

16,300

+4.5% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,247,147,285 across 329 Biotechnology names. LEXX ranks #314 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,714	16,300	+4.5%	Shares	Sole	2026-05-14
2025-12-31	$9,625	15,600	+54.5%	Shares	Sole	2026-02-12
2025-09-30	$9,625	10,100	-55.7%	Shares	Sole	2025-11-13
2024-06-30	—	22,800	+76.7%	Shares	Sole	2024-08-09
2023-09-30	—	12,900	+20.6%	Shares	Sole	2023-11-14
2023-06-30	—	10,700	-21.3%	Shares	Sole	2023-08-11
2023-03-31	—	13,600	+18.3%	Shares	Sole	2023-05-12
2022-12-31	—	11,500	-3.4%	Shares	Sole	2023-02-13
2022-09-30	—	11,900	+3.5%	Shares	Sole	2022-11-14
2022-06-30	—	11,500	-33.1%	Shares	Sole	2022-08-12
2021-06-30	—	17,200	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.